These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccination against rubella in Britain: benefits and risks. Freestone DS. Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680 [Abstract] [Full Text] [Related]
3. Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program. Swartz TA, Hornstein L, Epstein I. Rev Infect Dis; 1985; 7 Suppl 1():S42-6. PubMed ID: 4001732 [Abstract] [Full Text] [Related]
5. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. Anderson RM, Grenfell BT. J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044 [Abstract] [Full Text] [Related]
8. Success and failure of a rubella immunization programme. Swartz TA, Porath EB, Hornstein L. Dev Biol Stand; 1979 Apr; 43():355-60. PubMed ID: 520682 [Abstract] [Full Text] [Related]
16. [Susceptibility of pregnant women to rubella and the implications of immunization programs]. Villalbí JR, Graells C, Marín T. An Esp Pediatr; 1988 Feb 14; 28(2):137-40. PubMed ID: 3355032 [Abstract] [Full Text] [Related]
18. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination. Rossier E, Phipps PH, Polley JR, Webb T. Can Med Assoc J; 1977 Mar 05; 116(5):481-4. PubMed ID: 837312 [Abstract] [Full Text] [Related]